Orthocell unveils IPO plans

29/05/2014 - 15:26

Financial Services

Perth-based biotech firm Orthocell has confirmed it intends to list on the ASX after outlining plans for an $8 million initial public offering.

To read our articles you will need to either login or subscribe.

Your single user subscription provides more than you think